AIMS/HYPOTHESIS: Pathophysiological similarities between latent autoimmune diabetes in adults (LADA) and type 1 diabetes indicate an overlap in genetic susceptibility. HLA-DRB1 and HLA-DQB1 are major susceptibility genes for type 1 diabetes but studies of these genes in LADA have been limited. Our aim was to define patterns of HLA-encoded susceptibility/protection in a large, well characterised LADA cohort, and to establish association with disease and age at diagnosis. MATERIALS AND METHODS: Patients with LADA (n = 387, including 211 patients from the UK Prospective Diabetes Study) and non-diabetic control subjects (n = 327) were of British/Irish European origin. The HLA-DRB1 and -DQB1 genes were genotyped by sequence-specific PCR. RESULTS: As in type 1 diabetes mellitus, DRB1 0301_DQB1 0201 (odds ratio [OR] = 3.08, 95% CI 2.32-4.12, p = 1.2 x 10(-16)) and DRB1 0401_DQB1 0302 (OR = 2.57, 95% CI 1.80-3.73, p = 4.5 x 10(-8)) were the main susceptibility haplotypes in LADA, and DRB1 1501_DQB1 0602 was protective (OR = 0.21, 95% CI 0.13-0.34, p = 4.2 x 10(-13)). Differential susceptibility was conferred by DR4 subtypes: DRB1 0401 was predisposing (OR = 1.79, 95% CI 1.35-2.38, p = 2.7 x 10(-5)) whereas DRB1 0403 was protective (OR = 0.37, 95% CI 0.13-0.97, p = 0.033). The highest-risk genotypes were DRB1 0301/DRB1 0401 and DQB1 0201/DQB1 0302 (OR = 5.14, 95% CI 2.68-10.69, p = 1.3 x 10(-8); and OR = 6.88, 95% CI 3.54-14.68, p = 1.2 x 10(-11), respectively). These genotypes and those containing DRB1 0401 and DQB1 0302 associated with a younger age at diagnosis in LADA, whereas genotypes containing DRB1 1501 and DQB1 0602 associated with an older age at diagnosis. CONCLUSIONS/ INTERPRETATION: Patterns of susceptibility at the HLA-DRB1 and HLA-DQB1 loci in LADA are similar to those reported for type 1 diabetes, supporting the hypothesis that autoimmune diabetes occurring in adults is an age-related extension of the pathophysiological process presenting as childhood-onset type 1 diabetes.
AIMS/HYPOTHESIS: Pathophysiological similarities between latent autoimmune diabetes in adults (LADA) and type 1 diabetes indicate an overlap in genetic susceptibility. HLA-DRB1 and HLA-DQB1 are major susceptibility genes for type 1 diabetes but studies of these genes in LADA have been limited. Our aim was to define patterns of HLA-encoded susceptibility/protection in a large, well characterised LADA cohort, and to establish association with disease and age at diagnosis. MATERIALS AND METHODS:Patients with LADA (n = 387, including 211 patients from the UK Prospective Diabetes Study) and non-diabetic control subjects (n = 327) were of British/Irish European origin. The HLA-DRB1 and -DQB1 genes were genotyped by sequence-specific PCR. RESULTS: As in type 1 diabetes mellitus, DRB1 0301_DQB1 0201 (odds ratio [OR] = 3.08, 95% CI 2.32-4.12, p = 1.2 x 10(-16)) and DRB1 0401_DQB1 0302 (OR = 2.57, 95% CI 1.80-3.73, p = 4.5 x 10(-8)) were the main susceptibility haplotypes in LADA, and DRB1 1501_DQB1 0602 was protective (OR = 0.21, 95% CI 0.13-0.34, p = 4.2 x 10(-13)). Differential susceptibility was conferred by DR4 subtypes: DRB1 0401 was predisposing (OR = 1.79, 95% CI 1.35-2.38, p = 2.7 x 10(-5)) whereas DRB1 0403 was protective (OR = 0.37, 95% CI 0.13-0.97, p = 0.033). The highest-risk genotypes were DRB1 0301/DRB1 0401 and DQB1 0201/DQB1 0302 (OR = 5.14, 95% CI 2.68-10.69, p = 1.3 x 10(-8); and OR = 6.88, 95% CI 3.54-14.68, p = 1.2 x 10(-11), respectively). These genotypes and those containing DRB1 0401 and DQB1 0302 associated with a younger age at diagnosis in LADA, whereas genotypes containing DRB1 1501 and DQB1 0602 associated with an older age at diagnosis. CONCLUSIONS/ INTERPRETATION: Patterns of susceptibility at the HLA-DRB1 and HLA-DQB1 loci in LADA are similar to those reported for type 1 diabetes, supporting the hypothesis that autoimmune diabetes occurring in adults is an age-related extension of the pathophysiological process presenting as childhood-onset type 1 diabetes.
Authors: Minal Desai; Eleftheria Zeggini; Virginia A Horton; Katharine R Owen; Andrew T Hattersley; Jonathan C Levy; Graham A Hitman; Mark Walker; Rury R Holman; Mark I McCarthy; Anne Clark Journal: Diabetes Date: 2006-06 Impact factor: 9.461
Authors: J Graham; I Kockum; C B Sanjeevi; M Landin-Olsson; L Nyström; G Sundkvist; H Arnqvist; G Blohmé; F Lithner; B Littorin; B Scherstén; L Wibell; J Ostman; A Lernmark; N Breslow; G Dahlquist Journal: Eur J Immunogenet Date: 1999 Apr-Jun
Authors: V Horton; I Stratton; G F Bottazzo; M Shattock; I Mackay; P Zimmet; S Manley; R Holman; R Turner Journal: Diabetologia Date: 1999-05 Impact factor: 10.122
Authors: S Wiltshire; A T Hattersley; G A Hitman; M Walker; J C Levy; M Sampson; S O'Rahilly; T M Frayling; J I Bell; G M Lathrop; A Bennett; R Dhillon; C Fletcher; C J Groves; E Jones; P Prestwich; N Simecek; P V Rao; M Wishart; G F Bottazzo; R Foxon; S Howell; D Smedley; L R Cardon; S Menzel; M I McCarthy Journal: Am J Hum Genet Date: 2001-08-01 Impact factor: 11.025
Authors: Agnes Vatay; Katalin Rajczy; Eva Pozsonyi; Nóra Hosszúfalusi; Zoltán Prohászka; George Füst; István Karádi; Csaba Szalai; Andrea Grósz; Zoltán Bártfai; Pál Pánczél Journal: Immunol Lett Date: 2002-11-01 Impact factor: 3.685
Authors: Gunnar Stenström; Bo Berger; Henrik Borg; Per Fernlund; Janice S Dorman; Göran Sundkvist Journal: Am J Epidemiol Date: 2002-11-01 Impact factor: 4.897
Authors: Rebecka Hjort; Josefin E Löfvenborg; Emma Ahlqvist; Lars Alfredsson; Tomas Andersson; Valdemar Grill; Leif Groop; Elin P Sørgjerd; Tiinamaija Tuomi; Bjørn Olav Åsvold; Sofia Carlsson Journal: J Clin Endocrinol Metab Date: 2019-10-01 Impact factor: 5.958
Authors: Rajashree Mishra; Mikael Åkerlund; Diana L Cousminer; Emma Ahlqvist; Jonathan P Bradfield; Alessandra Chesi; Kenyaita M Hodge; Vanessa C Guy; David J Brillon; Richard E Pratley; Michael R Rickels; Adrian Vella; Fernando Ovalle; Ronald I Harris; Olle Melander; Stephen Varvel; Hakon Hakonarson; Phillippe Froguel; John T Lonsdale; Didac Mauricio; Nanette C Schloot; Kamlesh Khunti; Carla J Greenbaum; Knud B Yderstræde; Tiinamaija Tuomi; Benjamin F Voight; Stanley Schwartz; Bernhard O Boehm; Leif Groop; Richard David Leslie; Struan F A Grant Journal: Diabetes Care Date: 2019-12-16 Impact factor: 19.112